Press release
Clinical Trial Imaging Market Size to Surpass with a Growing CAGR of 7.9% by 2029, Share, Trends, Growth Strategies and Competitive Analysis
In a recently released analysis titled "Clinical Trial Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2029," Exactitude Consultancy, a reputable market research firm, provided data. The report offers a thorough overview of the market, including data on market size, trends, and growth projections for the global Clinical Trial Imaging market. The study highlights the most recent developments in the industry and provides competitor and geographical analysis."The global clinical trial imaging market is expected to grow at 7.9% CAGR from 2022 to 2029. It is expected to reach above USD 1.84 billion by 2029 from USD 0.92 billion in 2020."
Request for a free sample copy of this report-> https://exactitudeconsultancy.com/reports/5920/clinical-trial-imaging-market/#request-a-sample
**Note - Updated Version 2023 is available
► Growth Drivers
Spending on R&D is rising.
Pharmaceutical and imaging companies consistently spend in R&D to increase their market share and offer clients state-of-the-art clinical trial imaging services. Medical imaging has a dynamic impact on clinical advancement. Even though the medical imaging market is continually evolving as a result of the introduction of new technology, the imaging and pharmaceutical businesses are thriving.
Acquisitions and mergers, increased investment in the medical imaging sectors, the use of cutting-edge imaging technology to assist clinical trials for medical devices, and other factors are all credited with this. Market expansion is fueled by rising R&D expenditures by pharmaceutical and biotechnology companies.
► Who are the major players in this industry?
ICON plc., BioTelemetry, Inc., Biomedical Systems Corporation, Medpace Holdings, Inc., Bioclinica Inc, Ixico PLC, Intrinsic Imaging LLC, Radiant Sage LLC, and Parexel International Corporation, and others.
► New Developments in Clinical Trial Imaging Market
Recent developments in Clinical Trial Imaging industry, even after market report release, support market trends outlined in analysis.
» In March 2023, a healthcare research technology company, Clario, announced the launch of a cutting-edge cloud-based image viewer tool for sponsors and contract research organizations to view images related to their clinical trials. The newly launched tool for clinical images allows the whole access to read-quality images in real-time image viewer. The tool also empowers users to achieve valuable insights during clinical trials.
» In November 2022, a globally leading imaging intelligence company, VIDA, announced the launch of artificial intelligence (AI) based platform for clinical trial imaging operations, 'VIDA Intelligence Portal 2.0', with advanced efficiencies. According to the company, the platform is aimed to accelerate the onsite clinical trial imaging services. Along with the launch, VIDA is expecting collaboration with multiple hospitals and clinical centers.
ICON PLC purchased MedPass International, a European CRO, reimbursement, and regulatory consultant, in February 2020. According to reports, this acquisition has aided in the growth of ICON's medical device and diagnostic research services throughout Europe.
To provide PET imaging clinical trials for evaluating innovative therapies in China, Clario teamed with XingImaging, a radiopharmaceutical production and Positron Emission Tomography (PET) acquisition company, in January 2022. To accelerate the beginning of clinical trials and drug discovery in China, the cooperation provides to share of the combined resources and neuroscience specialists of Clario and XingImaging.
► What exactly does market segmentation cover?
Global Clinical Trial Imaging Market by Software And Services Type, 2020-2029, (USD Million)
» Operational Imaging Services
» Read Analysis Services
» Imaging Software
Global Clinical Trial Imaging Market by Modality Type, 2020-2029, (USD Million)
» CT
» MRI
» X-Ray
» Pet
» Ultrasound
» Echo
Global Clinical Trial Imaging Market by End Use, 2020-2029, (USD Million)
» Pharma
» Biotechnology
Contact Research Organization (Cro)
► Regional Analysis of the Clinical Trial Imaging Market
The market development, current market trends, and some research methodologies are all covered in the Clinical Trial Imaging Industry research report. It draws attention to crucial aspects like product portfolios, software architectures, and production strategies that have a direct impact on the market. Our research shows that even minor changes to a product's qualities can have a big impact on the previously mentioned criteria.
► Key Geographical Regions
» North America (US, Canada)
» Europe (Germany, UK, France, Italy, Spain)
» Asia-Pacific (China, Australia, Japan)
» Middle East and North Africa
» Latin America
► Table of Content:
1 Study Reporting
1.1 Clinical Trial Imaging Product
1.2 Key Segments in This Study
1.3 Key Companies Covered
1.4 Market by Type
1.4.1 Global Clinical Trial Imaging Market Size Growth Rate by Type
1.5 Market by Application
2 Executive Instantaneous
2.1 Global Clinical Trial Imaging Market Size
2.1.1 Global Clinical Trial Imaging Revenue
2.1.2 Global Clinical Trial Imaging Production
2.2 Clinical Trial Imaging Growth Rate (CAGR)
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio
2.3.2 Key Clinical Trial Imaging Manufacturers
2.3.2.1 Clinical Trial Imaging Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Clinical Trial Imaging Product Offered
2.3.2.3 Date of Manufacturers Enter into Clinical Trial Imaging Market
2.4 Key Trends for Clinical Trial Imaging Markets & Products
3 Market Size by Manufacturers
3.1 Clinical Trial Imaging Production by Manufacturers
3.2 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Imaging Production by Regions
4.1 Global Clinical Trial Imaging Production by Regions
4.1.1 Global Clinical Trial Imaging Production Market Share by Regions
4.1.2 Global Clinical Trial Imaging Revenue Market Share by Regions
4.2 United States
4.2.1 United States Clinical Trial Imaging Production
4.2.2 United States Clinical Trial Imaging Revenue
4.2.3 Key Players in United States
4.2.4 United States Clinical Trial Imaging Import & Export
4.3 Europe
4.3.1 Europe Clinical Trial Imaging Production
4.3.2 Europe Clinical Trial Imaging Revenue
5 Clinical Trial Imaging Consumption by Regions
5.1 Global Clinical Trial Imaging Consumption by Regions
5.1.1 Consumption by Regions
5.1.2 Consumption Market Share by Regions
5.2 North America
5.2.1 North America Consumption by Application
5.2.2 North America Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Consumption by Application
5.3.2 Europe Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Consumption by Application
5.4.2 Asia Pacific Consumption by Countries
5.5.1 Central & South America) Consumption by Application
5.5.2 Central & South America Consumption by Country
6 Market Size by Type
6.1 Production by Type
6.2 Revenue by Type
6.3 Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Clinical Trial Imaging Breakdown Dada by Application
7.2.1 Global Clinical Trial Imaging Consumption by Application
7.2.2 Global Clinical Trial Imaging Consumption Market Share by Application
8 Manufacturers Profiles
9 Production Forecasts
9.1 Clinical Trial Imaging Production and Revenue Forecast
9.1.1 Global Clinical Trial Imaging Production Forecast
9.1.2 Global Clinical Trial Imaging Revenue Forecast
9.2 Clinical Trial Imaging Production and Revenue Forecast by Regions
9.2.1 Global Clinical Trial Imaging Revenue Forecast by Regions
9.2.2 Global Clinical Trial Imaging Production Forecast by Regions
9.3 Clinical Trial Imaging Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Clinical Trial Imaging Production Forecast by Type
9.4.2 Global Clinical Trial Imaging Revenue Forecast by Type
10 Consumption Forecast
10.1 Clinical Trial Imaging Consumption Forecast by Application
10.2 Clinical Trial Imaging Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Clinical Trial Imaging Consumption Forecast by Regions
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Clinical Trial Imaging Consumption Forecast by Regions
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Clinical Trial Imaging Consumption Forecast by Regions
10.5.2 China
10.5.3 Japan
10.5.4 South Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Clinical Trial Imaging Consumption Forecast by Regions
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Clinical Trial Imaging Consumption Forecast by Regions
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Clinical Trial Imaging Sales Channels
11.2.2 Clinical Trial Imaging Distributors
11.3 Clinical Trial Imaging Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Key Findings in the Global Clinical Trial Imaging Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Continue….
Get a Sample Copy of the Clinical Trial Imaging Market Research Report (Use Corporate mail id for quick response)-@ https://exactitudeconsultancy.com/reports/5920/clinical-trial-imaging-market/#request-a-sample
► Customization Service of the Report:
Exactitude Consultancy offers personalized reports tailored to your specific needs, with a sales team dedicated to ensuring you receive a report that meets your specific requirements.
► Research Methodology
The report is based on data analysis strategies by skilled data analysts. The research methodology involves collecting and analyzing information to provide significant market predictions. Interviews with market influencers make primary research relevant and practical. The secondary method provides a direct insight into demand and supply. Both primary and secondary data collection methods are used, along with publicly available sources like annual reports and white papers, to provide a comprehensive understanding of the market. The report offers precise data analysis and a comprehensive market tour.
► Healthcare Trending Reports
https://www.openpr.com/news/3221597/clinical-chemistry-analyzers-market-size-is-projected-to-reach
https://www.openpr.com/news/3221633/clinical-microbiology-market-size-is-projected-to-reach-7-05
► About Us
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
► Connect Us:
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Trial Imaging Market Size to Surpass with a Growing CAGR of 7.9% by 2029, Share, Trends, Growth Strategies and Competitive Analysis here
News-ID: 3221672 • Views: …
More Releases from Exactitude Consultancy

Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Huntington's Disease (HD) is a devastating rare, inherited neurodegenerative disorder that progressively impairs movement, cognition, and behavior. Affecting approximately 3 to 7 individuals per 100,000 globally, it continues to challenge patients, caregivers, and healthcare systems. Despite being rare, the growing investment in research, clinical trials, and novel treatment approaches is transforming the Huntington's Disease market into a promising frontier for biopharmaceutical innovation.
The global Huntington's Disease market is poised for strong…

Hemophilia B Market Emerging Trends and Growth Prospects 2034
Introduction
Hemophilia B is a rare, inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX (FIX). Patients with Hemophilia B experience prolonged bleeding episodes, spontaneous internal hemorrhages, and joint damage, which can significantly impair quality of life. The disease predominantly affects males, with an estimated 1 in 25,000 male births worldwide.
For decades, the mainstay of treatment has been factor IX replacement therapy, delivered intravenously. However, repeated infusions,…

Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billi …
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), an autoimmune disease where the immune system attacks the body's own tissues. LN affects the kidneys, causing inflammation that can lead to organ damage and, if left untreated, kidney failure. With SLE most commonly affecting women of childbearing age, lupus nephritis represents a significant clinical and socioeconomic burden worldwide.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71619
The…

Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity …
Introduction
Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle disorder characterized by progressive weakness of facial, shoulder, and upper arm muscles, and eventually lower body muscles. It is the third most common type of muscular dystrophy, affecting approximately 1 in 8,000 to 1 in 20,000 individuals worldwide.
FSHD is typically caused by abnormal expression of the DUX4 gene due to genetic mutations on chromosome 4. While there is currently no approved…
More Releases for Imaging
Mobile Gamma Cameras Market 2018 -- 2028 | By Indication Type (Cardiac Imaging, …
Mobile gamma camera is a portable version of the stationary gamma or angler camera used for nuclear imaging. Nuclear imaging involves injecting a radio nucleotide in the body or organ under study and record the resulting redioactivity by scanning with a gamma camera. Nuclear imaging is performed owing to its better resolution and selectivity than non-nuclear imaging such as MRI and ultrasound.
The mobile gamma camera types include single, dual and…
Holographic Imaging Market Latest Technological Innovations on Holoxica, Zebra I …
Market Study Report Adds Global Holographic Imaging Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Emergence of 3D holographic imaging has revolutionized the medical imaging and surgery. The technology converts the given two dimensional MRI and CT scan imaging data into interactive virtual reality images. Using these images doctors…
Holographic Imaging Market : Eminent Players – EON Reality, Holoxica, Zebra Im …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc.
Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient…
Holographic Imaging Market Eminent Players – EON Reality, Holoxica, Zebra Imag …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc.
Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient anatomy…
Holographic Imaging Market Projections Reviewed On Holoxica, Zebra Imaging, Oviz …
The newly released research at Market Study Report titled “2017-2024 Global Holographic Imaging Consumption Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years.
Holographic Imaging Market size is set to exceed USD 3 billion by 2024. U.S. holographic imaging market accounted for significant industry share with expectations to witness healthy growth over coming years. Increasing biomedical research initiatives in holographic image…
Digital Imaging Market,Digital Imaging Industry, Global Digital Imaging Market,D …
Latest industry research report on: Global Digital Imaging Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
This report presents the worldwide Digital Imaging market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.
This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry…